Florida Cuts HIV/AIDS Funding, Blocking Thousands from Access to Meds – them.us

Report on Florida Department of Health’s Emergency Rule Impacting HIV/AIDS Medication Access

Introduction

Florida’s Department of Health (DOH) has enacted an emergency rule to reduce funding for the AIDS Drug Assistance Program (ADAP), resulting in approximately 16,000 individuals losing access to HIV/AIDS medications starting March 1. This report examines the implications of this decision, emphasizing its alignment with the Sustainable Development Goals (SDGs), particularly SDG 3: Good Health and Well-being, and SDG 10: Reduced Inequalities.

Background of the AIDS Drug Assistance Program (ADAP)

• Established in 1996 to assist low-income HIV and AIDS patients in affording medication.
• Previously served individuals earning up to 400% of the federal poverty level (~$62,600 annually).
• New eligibility criteria restrict assistance to those earning at or below 130% of the federal poverty level (~$20,345 annually).
• Insurance coverage for the HIV medication Biktarvy, used by 60% of ADAP enrollees, will also be limited.
• The emergency rule is effective for 90 days and is non-renewable.

Current Impact and Statistical Overview

1. Florida’s ADAP currently supports over 30,000 people living with HIV.
2. Approximately half of these individuals earn more than 139% of the federal poverty level, making them ineligible under the new rule.
3. Consequently, more than 16,000 people will lose affordable access to HIV/AIDS treatment.

Rationale Provided by Florida Department of Health

• Surgeon General Joseph Ladapo cited rising insurance premiums and federal funding cuts to the Ryan White HIV/AIDS program as reasons for the eligibility rollback.
• The Ryan White program is a critical federal funding source for state-level HIV/AIDS care initiatives.
• Proposed federal cuts in 2025 included a $1.7 billion reduction in HIV/AIDS funding, with $525 million cut from the Ryan White program, although these cuts were not enacted in the latest appropriations act.

Criticism and Legal Challenges

• Nonprofit organization AIDS United criticized the state’s decision, stating it contradicts public health principles and worsens the affordability crisis for HIV patients.
• The AIDS Healthcare Foundation (AHF) filed lawsuits against the DOH, arguing the emergency rule violates Florida’s Administrative Procedure Act due to lack of proper rulemaking process.
• AHF also seeks transparency through public records related to the eligibility changes.
• AHF’s legal actions aim to halt or reverse the implementation of the emergency rule.
• DOH has until March 6 to respond to the amended legal motion filed by AHF.

Implications for Sustainable Development Goals (SDGs)

1. SDG 3: Good Health and Well-being
   • The reduction in ADAP eligibility undermines efforts to ensure healthy lives and promote well-being for all, particularly for vulnerable populations living with HIV/AIDS.
   • Access to essential medicines is a core target under SDG 3, which is compromised by the funding cuts.
2. SDG 10: Reduced Inequalities
   • The policy disproportionately affects low-income individuals who rely on ADAP for medication access, exacerbating health disparities.
   • Limiting support to those below 130% of the federal poverty level excludes many who are still economically vulnerable.
3. SDG 16: Peace, Justice, and Strong Institutions
   • The controversy over the emergency rule highlights the importance of transparent and accountable governance in public health policymaking.
   • Legal challenges emphasize the need for adherence to procedural justice in administrative actions.

Conclusion

The Florida Department of Health’s emergency rule to cut ADAP funding presents significant challenges to public health and social equity, conflicting with key Sustainable Development Goals. The decision risks increasing health disparities and limiting access to life-saving HIV/AIDS medications for thousands of Floridians. Ongoing legal actions and public scrutiny underscore the critical need for policies that uphold health equity, transparency, and community well-being.

1. Sustainable Development Goals (SDGs) Addressed or Connected

1. SDG 3: Good Health and Well-being
   • The article focuses on HIV/AIDS treatment access, which directly relates to ensuring healthy lives and promoting well-being for all ages.
2. SDG 1: No Poverty
   • The eligibility changes based on income levels highlight issues related to poverty and access to healthcare for low-income populations.
3. SDG 10: Reduced Inequalities
   • The article discusses how funding cuts disproportionately affect vulnerable groups living with HIV/AIDS, reflecting inequalities in healthcare access.
4. SDG 16: Peace, Justice and Strong Institutions
   • The legal challenges against the Department of Health’s emergency rule relate to governance, transparency, and rule of law.

2. Specific Targets Under the Identified SDGs

1. SDG 3: Good Health and Well-being
   • Target 3.3: By 2030, end the epidemics of AIDS and other communicable diseases.
   • Target 3.8: Achieve universal health coverage, including access to quality essential health-care services and access to safe, effective, quality, and affordable essential medicines and vaccines for all.
2. SDG 1: No Poverty
   • Target 1.3: Implement nationally appropriate social protection systems and measures for all, including floors, and achieve substantial coverage of the poor and vulnerable.
3. SDG 10: Reduced Inequalities
   • Target 10.2: Empower and promote the social, economic and political inclusion of all, irrespective of age, sex, disability, race, ethnicity, origin, religion or economic or other status.
4. SDG 16: Peace, Justice and Strong Institutions
   • Target 16.6: Develop effective, accountable and transparent institutions at all levels.
   • Target 16.10: Ensure public access to information and protect fundamental freedoms.

3. Indicators Mentioned or Implied to Measure Progress

1. SDG 3 Indicators
   • Indicator 3.3.1: Number of new HIV infections per 1,000 uninfected population, by sex, age and key populations (implied by the discussion of HIV prevalence and treatment access).
   • Indicator 3.8.1: Coverage of essential health services (implied by the number of people accessing HIV/AIDS medications via ADAP).
   • Indicator 3.8.2: Proportion of population with large household expenditures on health as a share of total household expenditure or income (implied by affordability concerns raised in the article).
2. SDG 1 Indicators
   • Indicator 1.3.1: Proportion of population covered by social protection systems, by sex, distinguishing children, unemployed persons, older persons, persons with disabilities, pregnant women, newborns, work-injury victims and the poor and the vulnerable (implied by ADAP eligibility and coverage changes).
3. SDG 10 Indicators
   • Indicator 10.2.1: Proportion of people living below 50% of median income, by sex, age and persons with disabilities (implied by income eligibility criteria and exclusion of certain income groups).
4. SDG 16 Indicators
   • Indicator 16.6.2: Proportion of the population satisfied with their last experience of public services (implied by public dissatisfaction and legal challenges).
   • Indicator 16.10.2: Number of verified cases of killing, kidnapping, enforced disappearance, arbitrary detention and torture of journalists, associated media personnel, trade unionists and human rights advocates (not directly mentioned but relates to transparency and accountability concerns).

4. Table of SDGs, Targets and Indicators

Source: them.us